A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction—the China Rural Health Initiative Sodium Reduction Study
Nicole Li(George Institute for Global Health), Bruce Neal(UNSW Sydney), Wenyi Niu(Peking University), Darwin R. Labarthe(UK Health Forum), Michael M. Engelgau(World Bank), Paul Elliott(Ipsen (France)), Yangfeng Wu(Beijing Haidian Hospital), Lijing L. Yan(Duke University), Andrea Neiman, Yuhong Zhang(Central Hospital of Zibo), Ruijuan Zhang(Xi'an Jiaotong University), Xiangxian Feng(Changzhi Medical College), Jianxin Zhang(Hebei Provincial Center for Disease Control and Prevention), Hongling Chu
Cited by 51
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k